We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Molecular Diagnostics Prevents Malaria in Blood Banks

By LabMedica International staff writers
Posted on 18 Oct 2018
Haemovigilance is required to identify and prevent the occurrence or recurrence of unwanted transfusion-related transmissions and to increase the safety, efficacy and efficiency of blood transfusions.

Malaria can be transmitted by blood transfusion through donations collected from asymptomatic or parasitic donors. More...
The parasites are released into the bloodstream during its life cycle and will therefore be present in donated blood by infected individuals and can be fatal to the recipient.

Brazilian scientists collaborating with the Federal University of Pará (Belem, Brazil) obtained positive samples of Plasmodium vivax (22,000 parasites/µL) and P. malariae (400 parasites/µL) were obtained from patients with malaria and a positive sample of P. falciparum. Samples of potential donors were collected in two blood bank centers and among them, 1,324 were obtained from nine reference units and 900 were collected from blood donors in Porto Velho.

DNA samples were extracted from 150 µL blood by phenol/chloroform followed by ethanol precipitation method, with modifications. The DNA was quantified on NanoDrop ND 1000, in 260 nm to 280 nm wavelength range and final concentration was adjusted to 100 ng/µL. A real-time polymerase chain reaction (mt-qPCR) was performed to determine the presence and absence of the malaria parasite mitochondrial (mtDNA), based on primer extension and posterior hybridization with TaqMan probes on ABI Prism 7500 sequence detection system.

The team reported that malaria parasites were detected in 10 of 2,224 blood donors (0.45%). In all 10 positive samples, only P. vivax mtDNA was detected. The positivity for Plasmodium was observed in only three blood banks. The mt-qPCR was highly efficient, and the analytic sensitivity for P. vivax was determined (0.000006 parasites/µL). In samples collected in Porto Velho, only P. vivax was detected using both molecular diagnostic methods (mtDNA and 18S rRNA).

The authors concluded mt-qPCR is efficient for malaria molecular diagnostics, presenting promising results with good analytic sensitivity. It is a fast and easy molecular methodology to detect mtDNA of the three most frequent malaria parasites, presenting a potential for large-scale use in the prevention of transfusion-transmitted malaria by screening for potential donors as part of malaria haemovigilance in blood banks. The study was published on October 1, 2018, in the Malaria Journal.

Related Links:
Federal University of Pará


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: MG Tech adds STOMmics Stereo-seq spatial multi-omics technology to its potfolio (photo courtesy of STOmics)

MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.